Camp4 Therapeutics Corp — Form SCHEDULE 13D/A
Filed August 31, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
5AM Ventures VI, L.P. filed an amended Schedule 13D/A regarding beneficial ownership in Camp4 Therapeutics Corp. The filing provides no specific details on shareholding percentages, share counts, dollar amounts, or what substantive changes were made in this amendment. Without access to the actual document text beyond the cover page, the concrete terms of the amendment cannot be determined.
Why this rating
Schedule 13D amendments are routine disclosure updates. Without specific ownership changes, acquisition details, or material transaction terms disclosed, this appears administrative. Relative to $14.6M market cap, insufficient detail to assess impact.
See more from August 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.